Dear Colleague,

Communication was sent out by Dr Michael McBride, Chief Medical Officer and Prof Ian Young, Chief Scientific Advisor here on 17th September 2020 which provided up-to-date information available with regard to minimising the risk of COVID-19 outbreaks in healthcare settings.

With the introduction of the Community Pharmacy Flu Vaccination Service or resuming audit visits, you and your pharmacy team(s) may potentially be visiting community settings, such as residential and nursing homes.  The PHA have outlined key principles for HSC staff visiting community settings here which you may find useful.

Please share this advice with your pharmacy staff who may be visiting a community setting to deliver pharmacy services.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Dear Contractor

Update to Serious Shortage Protocols: Fluoxetine 40mg Capsules

The Department of Health has released updated information (attached) on the Serious Shortage Protocol (SSP) which was issued on 20 May 2020 in respect of fluoxetine 40mg capsules.

Summary

The SSP was issued with an end date of Monday 20 July 2020, which was extended until 2nd October 2020. The SSP has now been further extended until Friday 16th October 2020.Details of the SSP are available on the BSO website and can be accessed via this link: www.hscbusiness.hscni.net/services/3063.htm

Action

Contractors should:

  1. Brief their dispensing teams on the extension of the SSP.

CPNI colleagues will continue to support contractors on these matters.

Kind regards

Mike

Sent on behalf of Prof Mike Mawhinney | Head of Regulatory Affairs

Download

Dear Colleague,

FAO Pharmacies Contracted to Provide This Year’s HSCB Commissioned Flu Service

Please find attached for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

Dear Colleague,

FAO Pharmacies Contracted to Provide This Year’s HSCB Commissioned Flu Service

Please see email below from HSCB regarding the correct selection of employment status on the CPFV e-record.

ONLY FOR THE ATTENTION OF: CONTRACTORS PROVIDING FLU VACCINATION SERVICE FOR HEALTH & SOCIAL CARE WORKERS

HSCB CORRESPONDENCE: Urgent – Correct selection of employment status on the CFFV e-record

CPFV e-record – Essential to select the correct employment status.

We have had reports of Trust Occupational Health Departments receiving flu vaccination e-records for HSCWs that are not their employees.

It is essential that pharmacists ONLY select ‘Trust HCW’ or ‘Trust SCW’ on the CPFV e-record when they have checked the persons proof of identity and they are directly employed by the Trust or NIAS (as per staff identity badge / payslip / headed letter etc.)

All other HSCWs need to need logged as ‘Non-Trust Employed HSCW’

Copy of e-Record sent automatically to Trusts if ‘Trust HCW’ or ‘Trust SCW’ selected.

As noted in the Service Specification (9.5) – If trust employed, on submission all patient data will automatically be electronically sent to the relevant trust or NIAS occupational health department to allow them to capture relevant surveillance data.

Trusts must not receive patient data that does not relate to their staff so it is essential that pharmacists select the correct employment status and correct employer when completing the CPFV e–record form.

I’d be grateful if you could highlight this as a matter of urgency to any pharmacist providing the CPFV service.

If you have any queries about data entry on the CPFV e-record form please refer to the Help file on the BSO website or email me at: Greg.Miller@HSCNI.net

Kind regards,

Greg

Greg Miller, Pharmacy Advisor, Health & Social Care Board

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Dear Colleague,

HSCB CORRESPONDENCE: PPE LETTER – UPDATE AND REORDERING PROCESS

Please find attached for your attention, correspondence from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

Dear Colleague,

The final update of concessionary prices for September 2020 have been released and are as follows:

Drug Pack Size Concessionary Price
Duloxetine 40mg gastro-resistant capsules 56 £13.30
Entacapone 200mg tablets 30 £12.99
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets 28 £14.31
Moxonidine 200microgram tablets 28 £6.12
Moxonidine 300microgram tablets 28 £8.69
Moxonidine 400microgram tablets 28 £8.50
Nizatidine 150mg capsules 30 £7.01
Olanzapine 10mg tablets 28 £2.66
Olanzapine 2.5mg tablets 28 £1.51
Olanzapine 15mg tablets 28 £3.84
Oxytetracycline 250mg tablets 28 £8.85
Prednisolone 10mg tablets 30 £15.26
Prednisolone 2.5mg tablets 30 £3.80
Tamoxifen 20mg tablets 30 £14.69
Tolterodine 1mg tablets 56 £8.74
Valaciclovir 500mg tablets 10 £19.68
Valproic acid 300mg gastro-resistant capsules 100 £22.77
Zonisamide 100mg capsules 56 £62.72

The full list of concessionary prices can be found on our website www.communitypharmacyni.co.uk

Kind regards,

Katherine

SENT FOR AND BEHALF OF KATHERINE KIDD | Head of Pharmacy Development